Spániková Anna, Simoncíková Petra, Ravingerová Tána, Pechánová Olga, Barancík Miroslav
Institute for Heart Research, Centre of Excellence for Cardiovascular Research, Slovak Academy of Sciences, Dúbravská cesta 9, P.O. Box 104, 840 05 Bratislava, Slovak Republic.
Mol Cell Biochem. 2008 May;312(1-2):113-20. doi: 10.1007/s11010-008-9726-4. Epub 2008 Mar 10.
The aim of the present study was to characterize the effects of chronic nitric oxide synthase (NOS) inhibition on the alterations of regulatory myocardial proteins of intracellular signaling pathways (mitogen-activated protein kinase (MAPK) and Akt kinase cascades) and matrix metalloproteinases (MMP). Chronic NO deficiency (NOD) was induced by NG-nitro-L-arginine methyl ester (L-NAME, 40 mg/kg/day, 4 weeks). Protein levels and activation of protein kinases were determined using specific antibodies, activities of MMP were analyzed by zymography in gels containing gelatin as a substrate. The development of NOD was associated with decreased activation of endothelial NOS (eNOS) and down-regulation of protein level of inducible NOS (iNOS). Investigation of kinase pathways revealed that the activation of extracellular signal-regulated kinases (ERK) and the levels of upstream activators of ERK (aFGF, H-Ras) were decreased after L-NAME treatment. Western blot analysis revealed that chronic application of L-NAME also decreased the activation of Akt kinase as compared with control hearts. Study of MMPs showed that in L-NAME-treated rat hearts activities of tissue MMP-2 were decreased. It is concluded that development of NOD resulted in inhibition of ERK and Akt kinase pathways and these changes suggest the involvement of these cascades in responses of myocardium to NOD. The results also point to the possible relationship between ERK and Akt kinase pathways and activation of eNOS and/or MMP-2.
本研究的目的是描述慢性一氧化氮合酶(NOS)抑制对细胞内信号通路(丝裂原活化蛋白激酶(MAPK)和Akt激酶级联反应)的调节心肌蛋白及基质金属蛋白酶(MMP)改变的影响。通过给予NG-硝基-L-精氨酸甲酯(L-NAME,40mg/kg/天,共4周)诱导慢性一氧化氮缺乏(NOD)。使用特异性抗体测定蛋白激酶的蛋白水平和活性,通过以明胶为底物的凝胶酶谱分析MMP的活性。NOD的发展与内皮型一氧化氮合酶(eNOS)的激活降低和诱导型一氧化氮合酶(iNOS)的蛋白水平下调有关。激酶通路研究显示,L-NAME处理后细胞外信号调节激酶(ERK)的激活及ERK上游激活剂(aFGF、H-Ras)的水平降低。蛋白质印迹分析显示,与对照心脏相比,长期应用L-NAME也降低了Akt激酶的激活。MMP研究表明,在L-NAME处理的大鼠心脏中,组织MMP-2的活性降低。结论是,NOD的发展导致ERK和Akt激酶通路受到抑制,这些变化表明这些级联反应参与了心肌对NOD的反应。结果还指出了ERK和Akt激酶通路与eNOS和/或MMP-2激活之间可能存在的关系。